Literature DB >> 8168973

Partial destruction of Borrelia burgdorferi within ticks that engorged on OspE- or OspF-immunized mice.

T P Nguyen1, T T Lam, S W Barthold, S R Telford, R A Flavell, E Fikrig.   

Abstract

We determined whether Borrelia burgdorferi outer surface proteins (Osps) E and F could elicit immune responses useful for a Lyme disease vaccine. Thirty days after challenge with B. burgdorferi, mice produced antibodies to OspE but not OspF, whereas antibodies to OspF were present in sera of mice obtained 90 days after infection. Examination of sera from patients with Lyme disease revealed antibodies to OspF in a small number (14%) of early-stage disease patients but in a majority (58%) of patients with late-stage disease, while antibodies to OspE were rarely detected in patients. Mice immunized with recombinant OspE or OspF produced high titers of antibodies to OspE or OspF, respectively. OspF-immunized mice were partially protected from both intradermal syringe challenge and tick-mediated transmission of B. burgdorferi while vaccination with OspE did not confer immunity. B. burgdorferi organisms were, however, substantially destroyed within ticks that engorged on either OspE- (75% reduction in the number of spirochetes within the ticks, compared with controls) or OspF (90% reduction in the number of spirochetes within the ticks)-immunized mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8168973      PMCID: PMC186469          DOI: 10.1128/iai.62.5.2079-2084.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Serologic diagnosis of Lyme disease using recombinant outer surface proteins A and B and flagellin.

Authors:  E Fikrig; E D Huguenel; R Berland; D W Rahn; J A Hardin; R A Flavell
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

2.  Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB.

Authors:  J L Coleman; R C Rogers; J L Benach
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

3.  Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice.

Authors:  E Fikrig; S R Telford; S W Barthold; F S Kantor; A Spielman; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

4.  Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection.

Authors:  E Fikrig; S W Barthold; D H Persing; X Sun; F S Kantor; R A Flavell
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

5.  Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis.

Authors:  G Baranton; D Postic; I Saint Girons; P Boerlin; J C Piffaretti; M Assous; P A Grimont
Journal:  Int J Syst Bacteriol       Date:  1992-07

6.  Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.

Authors:  U E Schaible; R Wallich; M D Kramer; L Gern; J F Anderson; C Museteanu; M M Simon
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

7.  Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein.

Authors:  S J Norris; C J Carter; J K Howell; A G Barbour
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi.

Authors:  A L Armstrong; S W Barthold; D H Persing; D S Beck
Journal:  Am J Trop Med Hyg       Date:  1992-08       Impact factor: 2.345

9.  Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization.

Authors:  A Sădziene; P A Rosa; P A Thompson; D M Hogan; A G Barbour
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

10.  Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines.

Authors:  S R Telford; E Fikrig; S W Barthold; L R Brunet; A Spielman; R A Flavell
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  47 in total

Review 1.  Spirochaetal lipoproteins and pathogenesis.

Authors:  D A Haake
Journal:  Microbiology       Date:  2000-07       Impact factor: 2.777

2.  Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies.

Authors:  N D Ulbrandt; D R Cassatt; N K Patel; W C Roberts; C M Bachy; C A Fazenbaker; M S Hanson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Demonstration of the genetic stability and temporal expression of select members of the lyme disease spirochete OspF protein family during infection in mice.

Authors:  J V McDowell; S Y Sung; G Price; R T Marconi
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Differential immune responses to Borrelia burgdorferi in European wild rodent species influence spirochete transmission to Ixodes ricinus L. (Acari: Ixodidae).

Authors:  K Kurtenbach; A Dizij; H M Seitz; G Margos; S E Moter; M D Kramer; R Wallich; U E Schaible; M M Simon
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

5.  A 55-kilodalton antigen encoded by a gene on a Borrelia burgdorferi 49-kilobase plasmid is recognized by antibodies in sera from patients with Lyme disease.

Authors:  S Feng; S Das; T Lam; R A Flavell; E Fikrig
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo.

Authors:  R Wallich; C Brenner; M D Kramer; M M Simon
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.

Authors:  Y F Chang; M J Appel; R H Jacobson; S J Shin; P Harpending; R Straubinger; L A Patrican; H Mohammed; B A Summers
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi.

Authors:  B Stevenson; T G Schwan; P A Rosa
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Virulent strain associated outer membrane proteins of Borrelia burgdorferi.

Authors:  J T Skare; E S Shang; D M Foley; D R Blanco; C I Champion; T Mirzabekov; Y Sokolov; B L Kagan; J N Miller; M A Lovett
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

10.  Borrelia burgdorferi genes selectively expressed in the infected host.

Authors:  K Suk; S Das; W Sun; B Jwang; S W Barthold; R A Flavell; E Fikrig
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.